Under a research contract award granted by the Cystic Fibrosis Foundation Therapeutics (CFFT), Matinas BioPharma and the…
Articles by Daniela Semedo, PhD
The Gregory Fleming James Cystic Fibrosis Research Center (CFRC) at the University of Alabama at Birmingham (UAB) has acquired a …
Researchers at the University of Pittsburgh have been awarded with a $1.7 million grant from the National Institutes of Health (NIH)…
Pharmaxis has entered into a research collaboration with the Woolcock Institute of Medical Research in Sydney, Australia, to…
Celtaxsys recently announced that a second study describing the results of Phase 1 clinical trials evaluating acebilustat, an oral treatment for cystic…
ProQR Therapeutics is reporting that an early clinical study of QR-010 in cystic fibrosis patients homozygous for the ΔF508 mutation in the CFTR…
TGV-inhalonix reported that its therapeutic agent Mul-1867 is continuing to show promise in treating antibiotic-resistant lung infections — namely,…
Catabasis Pharmaceuticals announced that it will present data on CAT-5571, its investigational oral treatment for cystic fibrosis (CF). The drug has…
The National Heart, Lung and Blood Institute (NHLBI) of the National Institutes of Health (NIH) has granted a five-year, $13.3…
Aradigm Corporation and the Woolcock Institute are collaborating to develop cutting-edge nanotechnologies that target the bacterial and fungal biofilms often present in…